A comparative analysis of the HUGOTM robot-assisted surgery system and the Da Vinci® Xi surgical system for robot-assisted sacrocolpopexy for pelvic organ prolapse treatment

Claudia Collà Ruvolo; Margarita Afonina; Eleonora Balestrazzi; Marco Paciotti; Adele Piro; Federico Piramide; Carlo Andrea Bravi; Maria Peraire Lores; Gabriele Sorce; Mario Belmonte; Silvia Rebuffo; Marco Ticonosco; Nicola Frego; Giorgia Gaia; Ruben De Groote; Alexandre Mottrie; Geert De Naeyer

doi:10.1002/rcs.2587

A comparative analysis of the HUGO^TM robot-assisted surgery system and the Da Vinci^® Xi surgical system for robot-assisted sacrocolpopexy for pelvic organ prolapse treatment

Int J Med Robot. 2023 Oct 20:e2587. doi: 10.1002/rcs.2587. Online ahead of print.

Authors

Claudia Collà Ruvolo^{1

2

3}, Margarita Afonina^{1

2

4

5}, Eleonora Balestrazzi^{1

2

5}, Marco Paciotti^{1

2

6}, Adele Piro^{1

2

7}, Federico Piramide^{1

2

8}, Carlo Andrea Bravi^{1

2

9}, Maria Peraire Lores^{1

2}, Gabriele Sorce^{1

2

10}, Mario Belmonte^{1

2

11}, Silvia Rebuffo^{1

2

12}, Marco Ticonosco^{1

2

7}, Nicola Frego^{1

2

6}, Giorgia Gaia⁴, Ruben De Groote¹, Alexandre Mottrie^{1

2}, Geert De Naeyer¹

Affiliations

¹ Department of Urology, Onze-Lieve-Vrouwziekenhuis, Aalst, Belgium.
² ORSI Academy, Ghent, Belgium.
³ Department of Neurosciences, Reproductive Sciences and Odontostomatology, School of Medicine, University of Naples "Federico II", Naples, Italy.
⁴ Department of Obstetrics and Gynecology, San Paolo Hospital Medical School, University of Milan, Milan, Italy.
⁵ Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
⁶ Department of Urology, Humanitas Research Hospital- IRCCS, Rozzano, Italy.
⁷ Department of Urology, Ospedale Policlinico e Nuovo Ospedale Civile S.Agostino Estense Modena, University of Modena and Reggio Emilia, Modena, Italy.
⁸ Department of Oncology, Division of Urology, University of Turin, San Luigi Gonzaga Hospital, Turin, Italy.
⁹ Department of Urology, The Royal Marsden NHS Foundation Trust, London, UK.
¹⁰ Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
¹¹ Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
¹² Department of Urology, Policlinico San Martino Hospital, University of Genova, Genova, Italy.

PMID: 37864367
DOI: 10.1002/rcs.2587

Abstract

Background: We aimed to compare the outcomes of Robot-assisted sacrocolpopexy (RASC) performed using the novel HUGO^TM Robot-Assisted Surgery (RAS) System with the Da Vinci^® Xi surgical system.

Methods: Data from 38 women undergoing RASC for a ≥ 2-grade pelvic organ prolapse were collected (2021-2023).

Results: Overall, 23 (60.5%) and 15 (39.5%) procedures were performed using the DaVinci^® Xi and the HUGO^TM RAS system, respectively. The median total operative time was 123 (IQR:106.5-140.5) minutes for the DaVinci^® Xi versus 120 (IQR:120-146) minutes for the HUGO^TM RAS cases (p = 0.5). No conversion to open/laparoscopic surgery, perioperative complications, or system failures occurred. No differences were recorded according to day of catheter removal and length of stay.

Conclusions: This study represents the first worldwide comparison of RASC executed using the HUGO^TM RAS versus the Da Vinci^® Xi System. Our data suggest that RASC might be performed with both robotic platforms with similar perioperative outcomes.

Keywords: HUGO RAS system; pelvic floor surgery; pelvic organ prolapse; robotic surgery; sacrocolpopexy.